AMRI announces CEO retirement Albany Molecular Research announced that Thomas E. D'Ambra, Ph.D. will retire as president and CEO, effective December 31. Dr. D'Ambra will be named the company's non-executive chairman of the board on the same date. Dr. D'Ambra will be succeeded by William Marth, currently non-executive chairman of the AMRI board, effective January 1, 2014. Marth will remain a member of the company's board.
News For AMRI From The Last 14 Days
Check below for free stories on AMRI the last two weeks.